SLC26A3 and malignant colon neoplasm: Thus, consistent with published findings [see section Down-Regulated in Adenoma (SLC26A3, DRA)], SLC26A3 is down-regulated in colon cancer, but furthermore, our analyses reveal that this gene is also widely down-regulated in breast cancer (Figure 4).